Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVLN

Avalyn Pharma Inc

May 29 • 04:00PM ET

28.78

+0.39 1.37 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AAPG ABEO SPTX ABCL ABSI AARD ABOS ABVX ACET IVA

| Held by: VTI TMSL VXF VTWO VTWG TMED VTWV TNXT VTHR

Index	-	P/E	-	EPS (ttm)	-	Insider Own	66.90%	Shs Outstand	41.81M	Perf Week	1.30%
Market Cap	1.20B	Forward P/E	-	EPS next Y	-2.11	Insider Trans	5.22%	Shs Float	13.84M	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	5.99%	Short Float	4.06%	Perf Quarter	-
Income	-	P/S	-	EPS this Y	33.62%	Inst Trans	42.75%	Short Ratio	0.86	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	15.68%	ROA	-	Short Interest	0.56M	Perf YTD	-2.41%
Book/sh	-	P/C	-	EPS next 5Y	11.80%	ROE	-	52W High	32.22 -10.69%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	25.05 14.89%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.19% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	2.94	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.55	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	1.02%	Beta	-	Target Price	59.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	0.85%	Rel Volume	0.40	Prev Close	28.39
Employees	50	LT Debt/Eq	-	Earnings	-	SMA200	0.85%	Avg Volume	654.30K	Price	28.78
IPO	Apr 30, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	268,113	Change	1.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)